MedPath

Pharmaceutical Companies

Ownership
Public, Subsidiary
Established
2016-08-24
Employees
251
Market Cap
$101.9M
Website
http://www.i-mabbiopharma.com

CASI PHARMACEUTICALS INC.

🇰🇾Cayman Islands
Ownership
Public
Established
-
Employees
243
Market Cap
$100.6M
Website
http://www.casipharmaceuticals.com
Karyopharm Therapeutics Inc logo

Karyopharm Therapeutics Inc

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$99.7M
Website
-
Werewolf Therapeutics logo

Werewolf Therapeutics

🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
47
Market Cap
$99.6M
Website
http://www.werewolftx.com
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on...

Verastem Oncology

🇺🇸United States
Ownership
-
Established
2010-01-01
Employees
-
Market Cap
$99.4M
Website
https://www.verastem.com

Sagimet Biosciences

🇺🇸United States
Ownership
-
Established
-
Employees
10
Market Cap
$97.8M
Website
-
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and...

Oramed Pharmaceuticals

🇺🇸United States
Ownership
-
Established
-
Employees
15
Market Cap
$97.4M
Website
-
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used...

Intercure

🇺🇸United States
Ownership
-
Established
1994-01-01
Employees
-
Market Cap
$97M
Website
https://www.intercure.co/
HilleVax logo

HilleVax

🇺🇸United States
Ownership
Public
Established
-
Employees
90
Market Cap
$96M
Website
http://www.hillevax.com
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on...

INFLARX INC

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$95.9M
Website
-
© Copyright 2025. All Rights Reserved by MedPath